Skip to main content
Erschienen in: Child's Nervous System 9/2018

27.05.2018 | Original Paper

Spinal cord issues in adult patients with MPS: transition of care survey

verfasst von: Kemel A. Ghotme, Fernando Alvarado-Gomez, Christina Lampe, Klane K. White, Martha Solano-Villareal, Roberto Giugliani, Paul R. Harmatz

Erschienen in: Child's Nervous System | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aims to raise awareness of the need for research and appropriate guidelines for managing spinal cord issues in adult patients with mucopolysaccharidosis (MPS) and transition of these patients from pediatric to adult care.

Methods

Pediatric/adult neurosurgeons, orthopedic spine surgeons, and treating physicians with expertise in metabolic disorders and spinal cord issues were invited to complete a survey to assess their experience with spinal cord problems in MPS and their opinion on transitioning routes from pediatric to adult care.

Results

Twenty specialists completed the survey; 16 had treated spinal cord issues in patients with MPS. Foramen magnum and cervical stenosis (87%), atlanto-axial instability (67%), and lumbar spine instability (33%) were the main spinal cord issues encountered; 28% had treated adult patients for one or more spinal cord issues. In 40% of cases, this concerned an intervention or procedures performed during childhood. The main specialist responsible for the care of adult patients with MPS differed considerably between institutions and included both pediatric and adult specialists (30% pediatric neurosurgeons, 10% pediatric spine orthopedic surgeons, 30% adult spine neurosurgeons, 20% general adult surgeons). The preferred option (> 50%) for the transition of care was an interdisciplinary team of pediatric and adult specialists.

Conclusions

Further work needs to be done to address problems of managing spinal cord issues in adult patients with MPS. Currently, the responsibility for the care of patients with MPS with spinal cord issues is inconsistent. The best strategy for transitioning these patients from pediatric to adult care is likely an interdisciplinary approach.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Muenzer J (2011) Overview of the mucopolysaccharidoses. Rheumatology (Oxford) 50(Suppl 5):v4–v12CrossRef Muenzer J (2011) Overview of the mucopolysaccharidoses. Rheumatology (Oxford) 50(Suppl 5):v4–v12CrossRef
2.
Zurück zum Zitat Charrow J, Alden TD, Breathnach CAR, Frawley GP, Hendriksz CJ, Link B, Mackenzie WG, Manara R, Offiah AC, Solano ML, Theroux M (2015) Diagnostic evaluation, monitoring, and perioperative management of spinal cord compression in patients with Morquio syndrome. Mol Genet Metab 114:11–18CrossRefPubMed Charrow J, Alden TD, Breathnach CAR, Frawley GP, Hendriksz CJ, Link B, Mackenzie WG, Manara R, Offiah AC, Solano ML, Theroux M (2015) Diagnostic evaluation, monitoring, and perioperative management of spinal cord compression in patients with Morquio syndrome. Mol Genet Metab 114:11–18CrossRefPubMed
3.
Zurück zum Zitat Mitchell J, Berger KI, Borgo A, Braunlin EA, Burton BK, Ghotme KA, Kircher SG, Molter D, Orchard PJ, Palmer J, Pastores GM, Rapoport DM, Wang RY, White K (2016) Unique medical issues in adult patients with mucopolysaccharidoses. Eur J Intern Med 34:2–10CrossRefPubMed Mitchell J, Berger KI, Borgo A, Braunlin EA, Burton BK, Ghotme KA, Kircher SG, Molter D, Orchard PJ, Palmer J, Pastores GM, Rapoport DM, Wang RY, White K (2016) Unique medical issues in adult patients with mucopolysaccharidoses. Eur J Intern Med 34:2–10CrossRefPubMed
4.
Zurück zum Zitat Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill Medical Publishing Division, New York, pp 3421–3452 Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill Medical Publishing Division, New York, pp 3421–3452
5.
Zurück zum Zitat Harmatz PR, Shediac R (2017) Mucopolysaccharidosis VI: pathophysiology, diagnosis and treatment. Front Biosci 21, 22 Harmatz PR, Shediac R (2017) Mucopolysaccharidosis VI: pathophysiology, diagnosis and treatment. Front Biosci 21, 22
6.
Zurück zum Zitat Hendriksz CJ, Harmatz P, Beck M, Jones S, Wood T, Lachman R, Gravance CG, Orii T, Tomatsu S (2013) Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA. Mol Genet Metab 110:54–64CrossRefPubMedPubMedCentral Hendriksz CJ, Harmatz P, Beck M, Jones S, Wood T, Lachman R, Gravance CG, Orii T, Tomatsu S (2013) Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA. Mol Genet Metab 110:54–64CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Jurecka A, Opoka-Winiarska V, Jurkiewicz E, Marucha J, Tylki-Szymanska A (2012) Spinal cord compression in Maroteaux-Lamy syndrome: case report and review of the literature with effects of enzyme replacement therapy. Pediatr Neurosurg 48:191–198CrossRefPubMed Jurecka A, Opoka-Winiarska V, Jurkiewicz E, Marucha J, Tylki-Szymanska A (2012) Spinal cord compression in Maroteaux-Lamy syndrome: case report and review of the literature with effects of enzyme replacement therapy. Pediatr Neurosurg 48:191–198CrossRefPubMed
8.
Zurück zum Zitat Tomatsu S, Montaño AM, Oikawa H, Rowan DJ, Smith M, Barrera L, Chinen Y, Thacker MM, Mackenzie WG, Suzuki Y, Orii T (2011) Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment. Curr Pharm Biotechnol 12:931–945CrossRefPubMed Tomatsu S, Montaño AM, Oikawa H, Rowan DJ, Smith M, Barrera L, Chinen Y, Thacker MM, Mackenzie WG, Suzuki Y, Orii T (2011) Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment. Curr Pharm Biotechnol 12:931–945CrossRefPubMed
9.
Zurück zum Zitat Solanki GA, Alden TD, Burton BK, Giugliani R, Horovitz DDG, Jones SA, Lampe C, Martin KW, Ryan ME, Schaefer MK, Siddiqui A, White KK, Harmatz P (2012) A multinational, multidisciplinary consensus for the diagnosis and management of spinal cord compression among patients with mucopolysaccharidosis VI. Mol Genet Metab 107:15–24CrossRefPubMed Solanki GA, Alden TD, Burton BK, Giugliani R, Horovitz DDG, Jones SA, Lampe C, Martin KW, Ryan ME, Schaefer MK, Siddiqui A, White KK, Harmatz P (2012) A multinational, multidisciplinary consensus for the diagnosis and management of spinal cord compression among patients with mucopolysaccharidosis VI. Mol Genet Metab 107:15–24CrossRefPubMed
10.
Zurück zum Zitat Solanki GA, Martin KW, Theroux MC, Lampe C, White KK, Shediac R, Lampe CG, Beck M, Mackenzie WG, Hendriksz CJ, Harmatz PR (2013) Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management. J Inherit Metab Dis 36:339–355CrossRefPubMedPubMedCentral Solanki GA, Martin KW, Theroux MC, Lampe C, White KK, Shediac R, Lampe CG, Beck M, Mackenzie WG, Hendriksz CJ, Harmatz PR (2013) Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management. J Inherit Metab Dis 36:339–355CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat White KK, Harmatz P (2010) Orthopedic management of mucopolysaccharide disease. J Pediatr Rehabil Med 3:47–56PubMed White KK, Harmatz P (2010) Orthopedic management of mucopolysaccharide disease. J Pediatr Rehabil Med 3:47–56PubMed
12.
Zurück zum Zitat White KK (2011) Orthopaedic aspects of mucopolysaccharidoses. Rheumatology (Oxford) 50(Suppl 5):v26–v33CrossRef White KK (2011) Orthopaedic aspects of mucopolysaccharidoses. Rheumatology (Oxford) 50(Suppl 5):v26–v33CrossRef
13.
Zurück zum Zitat Hendriksz CJ, Berger KI, Giugliani R, Harmatz P, Kampmann C, Mackenzie WG, Raiman J, Villarreal MS, Savarirayan R (2015) International guidelines for the management and treatment of Morquio A syndrome. Am J Med Genet A 167A:11–25CrossRefPubMed Hendriksz CJ, Berger KI, Giugliani R, Harmatz P, Kampmann C, Mackenzie WG, Raiman J, Villarreal MS, Savarirayan R (2015) International guidelines for the management and treatment of Morquio A syndrome. Am J Med Genet A 167A:11–25CrossRefPubMed
14.
Zurück zum Zitat Kirkpatrick K, Ellwood J, Walker RWM (2012) Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: the impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management. Paediatr Anaesth 22:745–751CrossRefPubMed Kirkpatrick K, Ellwood J, Walker RWM (2012) Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: the impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management. Paediatr Anaesth 22:745–751CrossRefPubMed
15.
Zurück zum Zitat Linstedt U, Maier C, Joehnk H, Stephani U (1994) Threatening spinal cord compression during anesthesia in a child with mucopolysaccharidosis VI. Anesthesiology 80:227–229CrossRefPubMed Linstedt U, Maier C, Joehnk H, Stephani U (1994) Threatening spinal cord compression during anesthesia in a child with mucopolysaccharidosis VI. Anesthesiology 80:227–229CrossRefPubMed
16.
Zurück zum Zitat Suh SH, Okutani R, Nakasuji M, Nakata K (2010) Anesthesia in a patient with mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome). J Anesth 24:945–948CrossRefPubMed Suh SH, Okutani R, Nakasuji M, Nakata K (2010) Anesthesia in a patient with mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome). J Anesth 24:945–948CrossRefPubMed
17.
Zurück zum Zitat Jones SA, Almássy Z, Beck M, Burt K, Clarke JT, Giugliani R, Hendriksz C, Kroepfl T, Lavery L, Lin SP, Malm G, Ramaswami U, Tincheva R, Wraith JE, HOS Investigators (2009) Mortality and cause of death in mucopolysaccharidosis type II—a historical review based on data from the Hunter Outcome Survey (HOS). J Inherit Metab Dis 32:534–543CrossRefPubMed Jones SA, Almássy Z, Beck M, Burt K, Clarke JT, Giugliani R, Hendriksz C, Kroepfl T, Lavery L, Lin SP, Malm G, Ramaswami U, Tincheva R, Wraith JE, HOS Investigators (2009) Mortality and cause of death in mucopolysaccharidosis type II—a historical review based on data from the Hunter Outcome Survey (HOS). J Inherit Metab Dis 32:534–543CrossRefPubMed
18.
Zurück zum Zitat Lavery C, Hendriksz C (2015) Mortality in patients with Morquio Syndrome A. JIMD Rep 15:59–66PubMed Lavery C, Hendriksz C (2015) Mortality in patients with Morquio Syndrome A. JIMD Rep 15:59–66PubMed
19.
Zurück zum Zitat Quartel A, Harmatz PR, Lampe C, Guffon N, Ketteridge D, Leao-Teles E, Jones SA, Giugliani C (2018) Long-term galsulfase treatment associated with improved survival of patients with mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): 15 year follow-up from the survey study. JIEMS 6:1–6 Quartel A, Harmatz PR, Lampe C, Guffon N, Ketteridge D, Leao-Teles E, Jones SA, Giugliani C (2018) Long-term galsulfase treatment associated with improved survival of patients with mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): 15 year follow-up from the survey study. JIEMS 6:1–6
20.
Zurück zum Zitat Hendriksz CJ, Al-Jawad M, Berger KI, Hawley SM, Lawrence R, Mc Ardle C, Summers CG, Wright E, Braunlin E (2013) Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA. J Inherit Metab Dis 36:309–322CrossRefPubMed Hendriksz CJ, Al-Jawad M, Berger KI, Hawley SM, Lawrence R, Mc Ardle C, Summers CG, Wright E, Braunlin E (2013) Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA. J Inherit Metab Dis 36:309–322CrossRefPubMed
21.
Zurück zum Zitat Lampe C, Lampe C, Schwarz M, Müller-Forell W, Harmatz P, Mengel E (2013) Craniocervical decompression in patients with mucopolysaccharidosis VI: development of a scoring system to determine indication and outcome of surgery. J Inherit Metab Dis 36:1005–1013CrossRefPubMed Lampe C, Lampe C, Schwarz M, Müller-Forell W, Harmatz P, Mengel E (2013) Craniocervical decompression in patients with mucopolysaccharidosis VI: development of a scoring system to determine indication and outcome of surgery. J Inherit Metab Dis 36:1005–1013CrossRefPubMed
22.
Zurück zum Zitat Thümler A, Miebach E, Lampe C, Pitz S, Kamin W, Kampmann C, Link B, Mengel E (2012) Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series. J Inherit Metab Dis 35:1071–1079CrossRefPubMed Thümler A, Miebach E, Lampe C, Pitz S, Kamin W, Kampmann C, Link B, Mengel E (2012) Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series. J Inherit Metab Dis 35:1071–1079CrossRefPubMed
23.
Zurück zum Zitat White KK (2012) Orthopaedic surgery for mucopolysaccharidosis. Curr Orthop Pract 23:394–399CrossRef White KK (2012) Orthopaedic surgery for mucopolysaccharidosis. Curr Orthop Pract 23:394–399CrossRef
24.
Zurück zum Zitat Walker R, Belani KG, Braunlin EA, Bruce IA, Hack H, Harmatz PR, Jones S, Rowe R, Solanki GA, Valdemarsson B (2013) Anaesthesia and airway management in mucopolysaccharidosis. J Inherit Metab Dis 36:211–219CrossRefPubMed Walker R, Belani KG, Braunlin EA, Bruce IA, Hack H, Harmatz PR, Jones S, Rowe R, Solanki GA, Valdemarsson B (2013) Anaesthesia and airway management in mucopolysaccharidosis. J Inherit Metab Dis 36:211–219CrossRefPubMed
25.
Zurück zum Zitat Leone A, Rigante D, Amato DZ, Casale R, Pedone L, Magarelli N, Colosimo C (2015) Spinal involvement in mucopolysaccharidoses: a review. Childs Nerv Syst 31:203–212CrossRefPubMed Leone A, Rigante D, Amato DZ, Casale R, Pedone L, Magarelli N, Colosimo C (2015) Spinal involvement in mucopolysaccharidoses: a review. Childs Nerv Syst 31:203–212CrossRefPubMed
26.
Zurück zum Zitat Chehroudi C, MacNeily A (2016) Further thoughts on transition of care for spina bifida patients: experiences in BC. Can Urol Assoc J 10:377–378CrossRefPubMedPubMedCentral Chehroudi C, MacNeily A (2016) Further thoughts on transition of care for spina bifida patients: experiences in BC. Can Urol Assoc J 10:377–378CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Gleeson H, McCartney S, Lidstone V (2012) ‘Everybody’s business’: transition and the role of adult physicians. Clin Med 12:561–566CrossRef Gleeson H, McCartney S, Lidstone V (2012) ‘Everybody’s business’: transition and the role of adult physicians. Clin Med 12:561–566CrossRef
28.
Zurück zum Zitat Reiss JG, Gibson RW, Walker LR (2005) Health care transition: youth, family, and provider perspectives. Pediatrics 115:112–120CrossRefPubMed Reiss JG, Gibson RW, Walker LR (2005) Health care transition: youth, family, and provider perspectives. Pediatrics 115:112–120CrossRefPubMed
29.
Zurück zum Zitat van Staa AL, Jedeloo S, van Meeteren J, Latour JM (2011) Crossing the transition chasm: experiences and recommendations for improving transitional care of young adults, parents and providers. Child Care Health Dev 37:821–832CrossRefPubMed van Staa AL, Jedeloo S, van Meeteren J, Latour JM (2011) Crossing the transition chasm: experiences and recommendations for improving transitional care of young adults, parents and providers. Child Care Health Dev 37:821–832CrossRefPubMed
30.
Zurück zum Zitat Peters A, Laffel L, American Diabetes Association Transitions Working Group (2011) Diabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems: a position statement of the American Diabetes Association, with representation by the American College of Osteopathic Family Physicians, the American Academy of Pediatrics, the American Association of Clinical Endocrinologists, the American Osteopathic Association, the Centers for Disease Control and Prevention, Children with Diabetes, The Endocrine Society, the International Society for Pediatric and Adolescent Diabetes, Juvenile Diabetes Research Foundation International, the National Diabetes Education Program, and the Pediatric Endocrine Society (formerly Lawson Wilkins Pediatric Endocrine Society). Diabetes Care 34:2477–2485CrossRefPubMedPubMedCentral Peters A, Laffel L, American Diabetes Association Transitions Working Group (2011) Diabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems: a position statement of the American Diabetes Association, with representation by the American College of Osteopathic Family Physicians, the American Academy of Pediatrics, the American Association of Clinical Endocrinologists, the American Osteopathic Association, the Centers for Disease Control and Prevention, Children with Diabetes, The Endocrine Society, the International Society for Pediatric and Adolescent Diabetes, Juvenile Diabetes Research Foundation International, the National Diabetes Education Program, and the Pediatric Endocrine Society (formerly Lawson Wilkins Pediatric Endocrine Society). Diabetes Care 34:2477–2485CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Taylor MR, Edwards JG, Ku L (2006) Lost in transition: challenges in the expanding field of adult genetics. Am J Med Genet C Semin Med Genet 142C:294–303CrossRefPubMed Taylor MR, Edwards JG, Ku L (2006) Lost in transition: challenges in the expanding field of adult genetics. Am J Med Genet C Semin Med Genet 142C:294–303CrossRefPubMed
32.
Zurück zum Zitat Le JT, Mukherjee S (2015) Transition to adult care for patients with spina bifida. Phys Med Rehabil Clin N Am 26:29–38CrossRefPubMed Le JT, Mukherjee S (2015) Transition to adult care for patients with spina bifida. Phys Med Rehabil Clin N Am 26:29–38CrossRefPubMed
33.
Zurück zum Zitat Hendriksz CJ (2013) Transition services for adolescents with lysosomal storage disorders. CML—Lysosomal Storage Diseases 11:69–76 Hendriksz CJ (2013) Transition services for adolescents with lysosomal storage disorders. CML—Lysosomal Storage Diseases 11:69–76
34.
Zurück zum Zitat Callahan ST, Winitzer RF, Keenan P (2001) Transition from pediatric to adult-oriented health care: a challenge for patients with chronic disease. Curr Opin Pediatr 13:310–316CrossRefPubMed Callahan ST, Winitzer RF, Keenan P (2001) Transition from pediatric to adult-oriented health care: a challenge for patients with chronic disease. Curr Opin Pediatr 13:310–316CrossRefPubMed
35.
Zurück zum Zitat Fernandes SM, O’Sullivan-Oliveira J, Landzberg MJ, Khairy P, Melvin P, Sawicki GS, Ziniel S, Kenney LB, Garvey KC, Sobota A, O’Brien R, Nigrovic PA, Sharma N, Fishman LN (2014) Transition and transfer of adolescents and young adults with pediatric onset chronic disease: the patient and parent perspective. J Pediatr Rehabil Med 7:43–51PubMedPubMedCentral Fernandes SM, O’Sullivan-Oliveira J, Landzberg MJ, Khairy P, Melvin P, Sawicki GS, Ziniel S, Kenney LB, Garvey KC, Sobota A, O’Brien R, Nigrovic PA, Sharma N, Fishman LN (2014) Transition and transfer of adolescents and young adults with pediatric onset chronic disease: the patient and parent perspective. J Pediatr Rehabil Med 7:43–51PubMedPubMedCentral
36.
Zurück zum Zitat Sharma N, O’Hare K, Antonelli RC, Sawicki GS (2014) Transition care: future directions in education, health policy, and outcomes research. Acad Pediatr 14:120–127CrossRefPubMedPubMedCentral Sharma N, O’Hare K, Antonelli RC, Sawicki GS (2014) Transition care: future directions in education, health policy, and outcomes research. Acad Pediatr 14:120–127CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Van Lierde A, Menni F, Bedeschi MF, Natacci F, Guez S, Vizziello P, Costantino MA, Lalatta F, Esposito S (2013) Healthcare transition in patients with rare genetic disorders with and without developmental disability: neurofibromatosis 1 and Williams-Beuren syndrome. Am J Med Genet A 161A:1666–1674CrossRefPubMed Van Lierde A, Menni F, Bedeschi MF, Natacci F, Guez S, Vizziello P, Costantino MA, Lalatta F, Esposito S (2013) Healthcare transition in patients with rare genetic disorders with and without developmental disability: neurofibromatosis 1 and Williams-Beuren syndrome. Am J Med Genet A 161A:1666–1674CrossRefPubMed
38.
Zurück zum Zitat Rutishauser C, Sawyer SM, Ambresin AE (2014) Transition of young people with chronic conditions: a cross-sectional study of patient perceptions before and after transfer from pediatric to adult health care. Eur J Pediatr 173:1067–1074CrossRefPubMed Rutishauser C, Sawyer SM, Ambresin AE (2014) Transition of young people with chronic conditions: a cross-sectional study of patient perceptions before and after transfer from pediatric to adult health care. Eur J Pediatr 173:1067–1074CrossRefPubMed
Metadaten
Titel
Spinal cord issues in adult patients with MPS: transition of care survey
verfasst von
Kemel A. Ghotme
Fernando Alvarado-Gomez
Christina Lampe
Klane K. White
Martha Solano-Villareal
Roberto Giugliani
Paul R. Harmatz
Publikationsdatum
27.05.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Child's Nervous System / Ausgabe 9/2018
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-018-3834-6

Weitere Artikel der Ausgabe 9/2018

Child's Nervous System 9/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.